Cargando…

Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is more and more widely used in patients for various indications recent years. It is still intricate for clinicians to decide a suitable empiric antimicrobial dosing for patients receiving CRRT. Inappropriate doses of antimicrobial agents may lead to treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Lu, Li, Xin, Xia, Yanzhe, Chu, Yanqi, Zhong, Haili, Li, Jia, Liang, Pei, Bu, Yishan, Zhao, Rui, Liao, Yun, Yang, Ping, Lu, Xiaoyang, Jiang, Saiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273837/ https://www.ncbi.nlm.nih.gov/pubmed/32547394 http://dx.doi.org/10.3389/fphar.2020.00786

Ejemplares similares

Commentary: Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy
por: Matusik, Elodie
Publicado: (2020)

Dose Optimization of Teicoplanin for Critically Ill Patients With Renal Dysfunction and Continuous Renal Replacement Therapy: Experience From a Prospective Interventional Study
por: Shi, Lu, et al.
Publicado: (2022)

Antimicrobial Dosing Recommendations in Pediatric Continuous Renal Replacement Therapy: A Critical Appraisal of Current Evidence
por: Stitt, Gideon, et al.
Publicado: (2022)

Antimicrobial Doses in Continuous Renal Replacement Therapy: A Comparison of Dosing Strategies
por: Kempke, Anna P., et al.
Publicado: (2016)

Influence of continuous renal replacement therapy on the plasma concentration of tigecycline in patients with septic shock: A prospective observational study
por: Huang, Fang, et al.
Publicado: (2023)

Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
por: Schatz, Lea Marie, et al.
Publicado: (2023)

Doripenem Dosing Recommendations for Critically Ill Patients Receiving Continuous Renal Replacement Therapy
por: Samtani, Mahesh N., et al.
Publicado: (2012)

Impact of Bolus Dosing versus Continuous Infusion of Piperacillin and Tazobactam on the Development of Antimicrobial Resistance in Pseudomonas aeruginosa
por: Felton, T. W., et al.
Publicado: (2013)

Case Report: Therapeutic Drug Monitoring of Polymyxin B During Continuous Renal Replacement Therapy in Two Pediatric Patients: Do Not Underestimate Extracorporeal Clearance
por: Xu, Caifang, et al.
Publicado: (2022)

CYP2D6 Genotype-Based Dose Recommendations for Risperidone in Asian People
por: Cui, Yuanxia, et al.
Publicado: (2020)

Dosing patterns for continuous renal replacement therapy in the United States
por: Venkataraman, R, et al.
Publicado: (2001)

Continuous renal replacement therapy: are we getting the dose right?
por: Martin, S, et al.
Publicado: (2010)

Adsorption and caspofungin dosing during continuous renal replacement therapy
por: Honore, Patrick M., et al.
Publicado: (2019)

Lacosamide dosing in patients receiving continuous renal replacement therapy
por: Chaijamorn, Weerachai, et al.
Publicado: (2023)

Efficacy and safety of tailin formulation combined with continuous low-dose antibiotic therapy in patients with recurrent urinary tract infection: A multicenter, randomized, controlled clinical trial
por: Li, Tonglu, et al.
Publicado: (2022)

Polymyxin B in Patients With Renal Impairment: Is It Necessary to Adjust Dose?
por: Nie, Ruifang, et al.
Publicado: (2022)

Oral vinorelbine and continuous low doses of cyclophosphamide in pediatric rhabdomyosarcoma: a real-world study
por: Lan, Yingxia, et al.
Publicado: (2023)

Continuous Renal Replacement Therapy With oXiris Filter May Not be an Effective Resolution to Alleviate Cytokine Release Syndrome in Non-AKI Patients With Severe and Critical COVID-19
por: Kang, Kai, et al.
Publicado: (2022)

Distinction between induction and maintenance dosing in continuous renal replacement therapy
por: MacLaren, Graeme
Publicado: (2011)

Antimicrobial Dose Reduction in Continuous Renal Replacement Therapy: Myth or Real Need? A Practical Approach for Guiding Dose Optimization of Novel Antibiotics
por: Gatti, Milo, et al.
Publicado: (2021)

Optimizing Antimicrobial Dosing for Critically Ill Patients with MRSA Infections: A New Paradigm for Improving Efficacy during Continuous Renal Replacement Therapy
por: Chen, Jiaojiao, et al.
Publicado: (2022)

Development of a pediatric physiologically-based pharmacokinetic model to support recommended dosing of atezolizumab in children with solid tumors
por: Huang, Weize, et al.
Publicado: (2022)

Effect of replacement therapy (CRRT) and hemodialysis (IHD) on severe acute renal failure
por: Zhang, Xiangyuan, et al.
Publicado: (2023)

Population Pharmacokinetic Modeling and Simulation of TQ-B3101 to Inform Dosing in Pediatric Patients With Solid Tumors
por: Yang, Fen, et al.
Publicado: (2022)

Case Report: Respiratory paralysis associated with polymyxin B therapy
por: Ning, Yachan, et al.
Publicado: (2022)

Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy
por: Seyler, Lucie, et al.
Publicado: (2011)

Ginsenoside Rg3 Alleviates ox-LDL Induced Endothelial Dysfunction and Prevents Atherosclerosis in ApoE(−/−) Mice by Regulating PPARγ/FAK Signaling Pathway
por: Geng, Jianan, et al.
Publicado: (2020)

Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
por: Li, Guangyao, et al.
Publicado: (2022)

Continuous Renal Replacement Therapy Dosing in the Severely Underweight: A Case Report
por: Griffin, Benjamin R., et al.
Publicado: (2019)

Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy
por: Wenzler, Eric, et al.
Publicado: (2021)

Pharmacogenetics Based Dose Prediction Model for Initial Tacrolimus Dosing in Renal Transplant Recipients
por: Srinivas, Lekshmy, et al.
Publicado: (2021)

Adherence, belief, and knowledge about oral anticoagulants in patients with bioprosthetic heart valve replacement: a cross-sectional study
por: Ni, Yun-Xia, et al.
Publicado: (2023)

Impact of Healthcare Associated Infections on Survival and Treatment Outcomes Among End Stage Renal Disease Patients on Renal Replacement Therapy
por: Abbasi, Saad Hanif, et al.
Publicado: (2021)

Dose Dependent Antimicrobial Cellular Cytotoxicity—Implications for ex vivo Diagnostics
por: Copaescu, Ana, et al.
Publicado: (2021)

Antiviral Agent Therapy Optimization in Special Populations of COVID-19 Patients
por: Li, Lu, et al.
Publicado: (2020)

Ex Vivo Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and Vaborbactam
por: Sime, Fekade B., et al.
Publicado: (2018)

The Effectiveness of a Specialized Nursing Team Intervention in the Unplanned Interruption of Continuous Renal Replacement Therapy
por: Lu, Zhen, et al.
Publicado: (2022)

Corrigendum: Dose Dependent Antimicrobial Cellular Cytotoxicity—Implications for ex vivo Diagnostics
por: Copaescu, Ana, et al.
Publicado: (2021)

Clinical review: Timing and dose of continuous renal replacement therapy in acute kidney injury
por: Palevsky, Paul M
Publicado: (2007)

Evaluation of microcirculation before and during continuous renal replacement therapy and the impact of dose prescription
por: Pipili, C, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_a10iprjs22gbq8c50tgc98aglg